Works matching IS 1090820X AND DT 2021 AND VI 41 AND IP 12


Results: 47
    1
    2

    Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

    Published in:
    2021
    By:
    • Lorenc, Z Paul;
    • Adelglass, Jeffrey M;
    • Avelar, Rui L;
    • Baumann, Leslie;
    • Beer, Kenneth R;
    • Cohen, Joel L;
    • Cox, Sue Ellen;
    • Dayan, Steven H;
    • Dover, Jeffrey S;
    • Downie, Jeanine B;
    • Draelos, Zoe Diana;
    • Goldman, Mitchel P;
    • Gross, John E;
    • Joseph, John H;
    • Kaufman-Janette, Joely;
    • Moy, Ronald L;
    • Nestor, Mark;
    • Schlessinger, Joel;
    • Smith, Stacy R;
    • Weiss, Robert A
    Publication type:
    corrected article
    3
    6
    7
    8
    9
    10
    12
    13
    14
    15
    17
    18
    19
    21
    26
    27
    29
    30
    31
    32
    33
    35
    38
    39
    40
    41

    The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.

    Published in:
    2021
    By:
    • Lorenc, Z Paul;
    • Adelglass, Jeffrey M;
    • Avelar, Rui L;
    • Baumann, Leslie;
    • Beer, Kenneth R;
    • Cohen, Joel L;
    • Cox, Sue Ellen;
    • Dayan, Steven H;
    • Dover, Jeffrey S;
    • Downie, Jeanine B;
    • Draelos, Zoe Diana;
    • Goldman, Mitchel P;
    • Gross, John E;
    • Joseph, John H;
    • Kaufman-Janette, Joely;
    • Moy, Ronald L;
    • Nestor, Mark;
    • Schlessinger, Joel;
    • Smith, Stacy R;
    • Weiss, Robert A
    Publication type:
    journal article
    42
    43
    44
    45
    46
    47